A novel membrane-permeant cADPR antagonist modified in the pyrophosphate bridge

N Qi1, K Jung, M Wang

  • 1State Key Laboratory of Natural & Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Chemical Communications (Cambridge, England)
|July 26, 2011
PubMed